Cost-effectiveness of screening strategies for identifying pediatric diabetes mellitus and dysglycemia

Archives of Pediatrics and Adolescent Medicine

Volumn 167, Issue 1, 2013, Pages 32-39

  Wu, En Ling ^a   Kazzi, Nayla G ^a   Lee, Joyce M ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; CHILD; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DIABETIC PATIENT; DIAGNOSTIC TEST ACCURACY STUDY; DYSGLYCEMIA; HEALTH PROGRAM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MEDICARE; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PEDIATRICS; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SIMULATION; UNITED STATES; ARTICLE; HEALTH CARE COST; BLOOD; COMPARATIVE STUDY; COMPUTER SIMULATION; ECONOMICS; EVALUATION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; MASS SCREENING; METABOLISM; METHODOLOGY; STATISTICAL MODEL;

GLUCOSE; HEMOGLOBIN A1C; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADOLESCENT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHILD; COHORT STUDIES; COMPUTER SIMULATION; COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 2; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; MASS SCREENING; MEDICARE; MODELS, ECONOMIC; PREDIABETIC STATE; UNITED STATES;

MLCS; MLOWN;

EID: 84873497936     PISSN: 10724710     EISSN: 15383628     Source Type: Journal    
DOI: 10.1001/jamapediatrics.2013.419     Document Type: Note

References (37)

1. American Diabetes Association. Type 2 diabetes in children and adolescents. Pediatrics. 2000;105(3, pt 1):671-680.
2. Rhodes ET, Finkelstein JA, Marshall R, Allen C, Gillman MW, Ludwig DS. Screening for type 2 diabetes mellitus in children and adolescents: attitudes, barriers, and practices among pediatric clinicians. Ambul Pediatr. 2006;6(2):110-114.
3. Anand SG, Mehta SD, Adams WG. Diabetes mellitus screening in pediatric primary care. Pediatrics. 2006;118(5):1888-1895.
4. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(suppl 1):S62-S69.
5. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity in the United States, 2009-2010. NCHS Data Brief. 2012;(82):1-8.
6. Fagot-Campagna A, Saaddine JB, Engelgau MM. Is testing children for type 2 diabetes a lost battle? Diabetes Care. 2000;23(9):1442-1443.
7. Edgell C. Costs of screening are important. BMJ. 1993;306(6880):797.
8. Grimes DA, Schulz KF. Uses and abuses of screening tests. Lancet. 2002;359(9309):881-884.
9. Dolan LM, Bean J, D'Alessio D, et al. Frequency of abnormal carbohydrate metabolism and diabetes in a population-based screening of adolescents. J Pediatr. 2005;146(6):751-758.
10. Lee JM. Why young adults hold the key to assessing the obesity epidemic in children. Arch Pediatr Adolesc Med. 2008;162(7):682-687.
11. Liese AD, D'Agostino RB Jr, Hamman RF, et al SEARCH for Diabetes in Youth Study Group. The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics. 2006;118(4):1510-1518.
12. Zhang P, Engelgau MM, Valdez R, Benjamin SM, Cadwell B, Narayan KM. Costs of screening for pre-diabetes among US adults: a comparison of different screening strategies. Diabetes Care. 2003;26(9):2536-2542.
13. Zhang P, Engelgau MM, Valdez R, Cadwell B, Benjamin SM, Narayan KM. Efficient cutoff points for three screening tests for detecting undiagnosed diabetes and pre-diabetes: an economic analysis. Diabetes Care. 2005;28(6):1321-1325.
14. May AL, Kuklina EV, Yoon PW. Prevalence of cardiovascular disease risk factors among US adolescents, 1999-2008. Pediatrics. 2012;129(6):1035-1041.
15. Cowie CC, Rust KF, Ford ES, et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care. 2009;32(2):287-294.
16. Knowler WC, Barrett-Connor E, Fowler SE, et al Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.
17. Li C, Ford ES, Zhao G, Mokdad AH. Prevalence of pre-diabetes and its association with clustering of cardiometabolic risk factors and hyperinsulinemia among U.S. adolescents: National Health and Nutrition Examination Survey 2005-2006. Diabetes Care. 2009;32(2):342-347.
18. Johnson SL, Tabaei BP, Herman WH. The efficacy and cost of alternative strategies for systematic screening for type 2 diabetes in the U.S. population 45-74 years of age. Diabetes Care. 2005;28(2):307-311.
19. American Diabetes Association. Standards of medical care in diabetes - 2010. Diabetes Care. 2010;33(suppl 1):S11-S61.
20. 1c for diagnosing prediabetes and diabetes in obese children and adolescents. Diabetes Care. 2011;34(6):1306-1311.
21. Lee JM, Gebremariam A, Wu EL, LaRose J, Gurney JG. Evaluation of nonfasting tests to screen for childhood and adolescent dysglycemia. Diabetes Care. 2011;34(12):2597-2602.
22. Physician fee schedule. Centers for Medicare & Medicaid Services website. 2011. https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/ PhysicianFeeSched/index.html?redirect=/PhysicianFeeSched/. Accessed October 13, 2011.
23. US Department of Labor. Occupational employment statistics. Bureau of Labor Statistics website. 2011. http://bls.gov/oes/. Accessed September 22, 2011.
24. Chatterjee R, Narayan KM, Lipscomb J, Phillips LS. Screening adults for prediabetes and diabetes may be cost-saving. Diabetes Care. 2010;33(7):1484- 1490.
25. Pinhas-Hamiel O, Dolan LM, Daniels SR, Standiford D, Khoury PR, Zeitler P. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr. 1996;128(5, pt 1):608-615.
26. Pavkov ME, Hanson RL, Knowler WC, Bennett PH, Krakoff J, Nelson RG. Changing patterns of type 2 diabetes incidence among Pima Indians. Diabetes Care. 2007;30(7):1758-1763.
27. Goran MI, Davis J, Kelly L, et al. Low prevalence of pediatric type 2 diabetes: where's the epidemic? J Pediatr. 2008;152(6):753-755.
28. Diabetes Prevention Program Research Group. Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes. Diabetes Care. 2003;26(9):2518-2523.
29. Diabetes Prevention Program Research Group. The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS. Diabetes Care. 2012;35(4):723-730.
30. Zeitler P, Hirst K, Pyle L, et al TODAY Study Group. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med. 2012;366(24):2247-2256.
31. Gillman MW. Predicting prediabetes and diabetes: can we do it? Is it worth it? Arch Pediatr Adolesc Med. 2010;164(2):198-199.
32. Benson LJ, Baer HJ, Kaelber DC. Screening for obesity-related complications among obese children and adolescents: 1999-2008. Obesity (Silver Spring). 2011;19(5):1077-1082.
33. Lee JM, Wu EL, Tarini B, Herman WH, Yoon E. Diagnosis of diabetes using hemoglobin A1c: should recommendations in adults be extrapolated to adolescents? J Pediatr. 2011;158(6):947-952.
34. Phillips LS, Ziemer DC, Kolm P, et al. Glucose challenge test screening for prediabetes and undiagnosed diabetes. Diabetologia. 2009;52(9):1798-1807.
35. Sinha R, Fisch G, Teague B, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity (published correction appears in N Engl J Med. 2002;30:346[22]:1756). N Engl J Med. 2002;346(11):802-810.
36. Libman IM, Barinas-Mitchell E, Bartucci A, Robertson R, Arslanian S. Reproducibility of the oral glucose tolerance test in overweight children. J Clin Endocrinol Metab. 2008;93(11):4231-4237.
37. Shaw JE, d'Emden MC, Goodall I. Is Australia ready to use glycated haemoglobin for the diagnosis of diabetes? Med J Aust. 2011;195(1):7-8.